2025 Spring Research Seed Grants launch projects on rheumatoid arthritis and balance disorders. Two early-stage research projects at SIU School of Medicine are taking on complex, chronic diseases that affect millions, with the help of focused funding designed to plant the seeds of future discovery. The Spring 2025 Research Seed Grants, awarded by the associate dean for research , support SIU School of Medicine faculty in generating data that could lead to larger, external grants. This year’s recipients are Brandon Cox , PhD, professor and director of the Multidisciplinary Biomedical &

Predictors of red blood cell transfusion effectiveness: From bench to bedside Tuesday, August 26 | 8-9 a.m. Simmons Cancer Institute, Woerner Conference Room, 1st Floor Nareg Roubinian, MD, MPHTM is an investigator at Vitalant Research Institute, adjunct faculty at UCSF and senior physician in pulmonary and critical care medicine at Kaiser Permanente Oakland. This lecture is part of the inaugural Visiting Lectures on Hematologic Disorders to correspond with the investiture of Ruchika Goel , MD, MPH, as the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders .

Predictors of red blood cell transfusion effectiveness: From bench to bedside Tuesday, August 26 | 8-9 a.m. Simmons Cancer Institute, Woerner Conference Room, 1st Floor Nareg Roubinian, MD, MPHTM is an investigator at Vitalant Research Institute, adjunct faculty at UCSF and senior physician in pulmonary and critical care medicine at Kaiser Permanente Oakland. This lecture is part of the inaugural Visiting Lectures on Hematologic Disorders to correspond with the investiture of Ruchika Goel , MD, MPH, as the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders .

Transfusion medicine, hematology and global health Monday, August 25 | 4:30-5 p.m. Memorial Learning Center, 2A Curtis Theater Classroom, 2nd Floor, 228 W. Miller St., Springfield Evan Bloch, MD is professor of pathology at Johns Hopkins University School of Medicine, associate director of transfusion medicine and medical director of the Apheresis Service. He also holds a joint appointment in International Health at the Johns Hopkins Bloomberg School of Public Health. This lecture is part of the inaugural Visiting Lectures on Hematologic Disorders to correspond with the investiture of Ruchika

Transfusion medicine, hematology and global health Monday, August 25 | 4:30-5 p.m. Memorial Learning Center, 2A Curtis Theater Classroom, 2nd Floor, 228 W. Miller St., Springfield Evan Bloch, MD is professor of pathology at Johns Hopkins University School of Medicine, associate director of transfusion medicine and medical director of the Apheresis Service. He also holds a joint appointment in International Health at the Johns Hopkins Bloomberg School of Public Health. This lecture is part of the inaugural Visiting Lectures on Hematologic Disorders to correspond with the investiture of Ruchika

Artificial intelligence and the AI revolution at the intersection of hematology and transfusion medicine Monday, August 25 | 4–4:30 p.m. Memorial Learning Center, 2A Curtis Theater Classroom, 2nd Floor, 228 W. Miller St., Springfield Cassandra Josephson, MD is the Hawkins Family Endowed Chair in the Cancer and Blood Disorders Institute and Professor of Oncology, Johns Hopkins University School of Medicine. She is also the director of the Johns Hopkins All Children’s Cancer & Blood Disorders Institute in St. Petersburg, Florida. This lecture is part of the inaugural Visiting Lectures on

Artificial intelligence and the AI revolution at the intersection of hematology and transfusion medicine Monday, August 25 | 4–4:30 p.m. Memorial Learning Center, 2A Curtis Theater Classroom, 2nd Floor, 228 W. Miller St., Springfield Cassandra Josephson, MD is the Hawkins Family Endowed Chair in the Cancer and Blood Disorders Institute and Professor of Oncology, Johns Hopkins University School of Medicine. She is also the director of the Johns Hopkins All Children’s Cancer & Blood Disorders Institute in St. Petersburg, Florida. This lecture is part of the inaugural Visiting Lectures on

At SIU School of Medicine, the story of hypertension research doesn’t begin in a distant lab. It begins in the clinic, often with a patient who has run out of options. A provider reviews the numbers. Despite multiple medications, lifestyle changes and follow-up visits, blood pressure remains stubbornly high. In that moment, a different path forward is offered: enrollment in a clinical trial conducted by SIU’s Hypertension Clinic. These trials are not theoretical with no practical outcome. They are active, evidence-based and available right here in central and southern Illinois. One of SIU’s

At SIU School of Medicine, the story of hypertension research doesn’t begin in a distant lab. It begins in the clinic, often with a patient who has run out of options. A provider reviews the numbers. Despite multiple medications, lifestyle changes and follow-up visits, blood pressure remains stubbornly high. In that moment, a different path forward is offered: enrollment in a clinical trial conducted by SIU’s Hypertension Clinic. These trials are not theoretical with no practical outcome. They are active, evidence-based and available right here in central and southern Illinois. One of SIU’s

At SIU School of Medicine, the story of hypertension research doesn’t begin in a distant lab. It begins in the clinic, often with a patient who has run out of options. A provider reviews the numbers. Despite multiple medications, lifestyle changes and follow-up visits, blood pressure remains stubbornly high. In that moment, a different path forward is offered: enrollment in a clinical trial conducted by SIU’s Hypertension Clinic. These trials are not theoretical with no practical outcome. They are active, evidence-based and available right here in central and southern Illinois. One of SIU’s